TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) is now available.
Dawnrays Pharmaceutical Holdings Ltd. has announced its upcoming Annual General Meeting scheduled for May 23, 2025, in Hong Kong. Key agenda items include the consideration of financial statements for the year ending December 31, 2024, the declaration of final and special dividends, re-election of directors, and authorization for the board to manage director remunerations and re-appoint auditors. Additionally, a resolution will be considered to empower the directors to issue additional shares, which could influence the company’s capital structure and shareholder value.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It is listed on the Hong Kong Stock Exchange and focuses on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: -5.74%
Average Trading Volume: 243,654
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.73B
For a thorough assessment of 2348 stock, go to TipRanks’ Stock Analysis page.